MO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Altria Group Inc (MO) is not a strong buy at this moment for a beginner investor with a long-term strategy. While the stock offers a high dividend yield and stability in the consumer staples sector, declining sales, weak financial performance, and mixed analyst ratings suggest limited growth potential. The technical indicators and options data do not provide compelling entry signals for immediate investment.
The technical indicators show mixed signals. The MACD is positive but contracting, indicating weakening momentum. RSI is neutral, suggesting no overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading near resistance levels (R1: 69.732). The stock has a 60% chance of minor declines in the short term (-0.03% next day, -2.71% next week).
Altria offers a high dividend yield of 6.3%, which is attractive for income-focused investors. The company recently declared a quarterly dividend of $1.06 per share, reflecting its commitment to shareholder returns. Consumer staples are seen as a safe haven during market uncertainty.
raise concerns about the company's ability to sustain its dividend long-term. Analysts have mixed ratings, with some highlighting risks like declining nicotine pouch volumes and slower smoke-free progress. The stock's growth potential appears limited in the short term.
In Q4 2025, Altria's revenue dropped by -0.53% YoY to $5.08 billion. Net income plunged by -63.25% YoY to $1.11 billion, and EPS fell by -63.13% YoY to $0.66. While gross margin slightly improved to 70.66%, the overall financial performance was weak, reflecting higher operating costs and declining sales.
Analysts have mixed views. Barclays raised the price target to $63 but maintained an Underweight rating. BofA and UBS are more optimistic, with price targets of $72 and $67, respectively, citing manageable risks and potential EPS acceleration in 2026-2027. Stifel lowered its price target to $68, citing softer-than-expected operating performance.
